论文部分内容阅读
随着对乳腺癌生物学行为的深入研究,已证明乳腺癌是一种全身性疾病,单纯扩大手术切除范围并不能取得更好的疗效。乳腺癌保乳术与根治术在无病生存率、远处转移率和总生存率方面相比较均无差别。保乳术已成为西方国家治疗早期乳腺癌的一种标准,在美国每年约有20%～50%的早期乳腺癌接受保乳治疗,已渐为广大女性患者所接受。本文对乳腺癌保乳术的适应证及其相关技术的进展作一综述。1 乳腺癌保乳治疗的适应证目前国际上对乳腺癌保乳治疗的适应证尚无统一规定,
With the in-depth study of biological behavior of breast cancer, breast cancer has been proved to be a systemic disease, simply expanding the scope of surgical resection and can not achieve better efficacy. Breast conserving surgery and radical mastectomy in disease-free survival rate, distant metastasis rate and overall survival rate compared with no difference. It has become a standard for treating early breast cancer in western countries. In the United States, about 20% to 50% of all breast cancer patients receive breast-conserving treatment every year, which is gradually accepted by the majority of female patients. This article reviews the indications of breast conserving surgery and the progress of related technologies. A breast conserving treatment indications At present, there is no uniform regulation on the indications for breast conserving treatment in the world,